Synergistic effects of Chinese herbal formula combined with Microcin J25 against Escherichia coli and Salmonella in calf diarrhea and clinical evaluation of preventive and therapeutic effects in the Ningxia region

Introduction: Calf diarrhea is one of the most common diseases causing significant economic losses in the livestock industry. This article aims to investigate the bacterial causes of calf diarrhea in the Ningxia region and to evaluate the synergistic antibacterial effect of Chinese Herbal Formula (CHF) and Microcin J25 (MccJ25) on pathogenic bacteria, as well as its clinical prevention and treatment effects on calf diarrhea.

Methods: A total of 100 diarrheic fecal samples were collected from calves across 10 cattle farms in the Ningxia region. Bacterial isolation and identification were performed to detect E. coli and Salmonella strains. The in vitro synergistic antibacterial effects of a Chinese Herbal Formula (CHF) combined with Microcin J25 (MccJ25) were evaluated using antimicrobial susceptibility testing. Furthermore, in vivo prevention and treatment trials were conducted to assess the efficacy of the CHF-MccJ25 combination against calf diarrhea, including evaluation of clinical symptoms, fecal microbial composition, and immune parameters.

Results: The results showed that out of 100 diarrheic calves fecal samples were collected from 10 cattle farms in the Ningxia Hui Autonomous Region. 97 E. coli strains and 20 Salmonella strains were detected. In vitro, the combination of Chinese Herbal Formula (CHF) and Microcin J25(MCJ) showed a synergistic inhibitory effect against E. coli and Salmonella. Moreover, the combined treatment also exhibited virulence-inhibitory activity. In vivo, the combination effectively reduced the incidence of diarrhea in healthy calves in a dose-dependence.

Discussion: In summary, our study indicated that the combination of Chinese Herbal Formula (CHF) and Microcin J25(MCJ) effectively combated multidrug-resistant E. coli and Salmonella, improving both prevention and treatment of calf diarrhea by enhancing immunity and restoring gut microbiota balance.

Introduction

Calf diarrhea is a severe disease affecting the livestock industry worldwide, particularly among neonatal calves, where it remains one of the leading causes of mortality (1). The condition is primarily triggered by pathogenic microbial infections, such as E. coli, Salmonella, and other gastrointestinal pathogens (2). Diarrhea predominantly affects calves within the first 30 days of life, and in severe cases, not only impairs normal growth and development but also adversely affects the reproductive and lactational performance of dairy cows, thereby imposing substantial economic losses on the cattle industry (3, 4).

In veterinary clinical practice, antibiotics are commonly used to treat calf diarrhea (5–7). However, the overuse and misuse of antibiotics have led to escalating antimicrobial resistance, diminishing therapeutic efficacy, and raising concerns about drug residues in animal products (8–10). More critically, long-term antibiotic use may result in recurrent diarrhea and exacerbate intestinal dysbiosis (11). Therefore, the development of safe and effective alternatives to antibiotics for managing calf diarrhea has become a focal point of current research.

Chinese Herbal Formula (CHF) has a long history in the prevention and treatment of diseases in animals. As a natural therapeutic agent, it offers advantages such as low toxicity, minimal residue, and a lack of drug resistance (12, 13). Moreover, CHF is known as antibiotic alternative, which is used to modulate physiological functions, enhance immunity, and regulate gut microbiota (14, 15), incomplete sentence, should be “making them widely used in livestock production.

Antimicrobial peptides (AMPs), representing a novel category of antibiotic substitutes, have gained considerable attention in the control of diseases in livestock and poultry (16). Microcin J25, a naturally occurring AMP, exhibits potent bactericidal activity against a variety of pathogens, particularly E. coli and Salmonella (17–19). Additionally, it has been shown to improve gut health and prevent intestinal inflammation in animals. Importantly, Microcin J25 is efficient, safe, and less prone to inducing bacterial resistance (20–23).

This study aims to explore the combined use of CHF and antimicrobial peptides as a novel strategy for the prevention and treatment of calf diarrhea.

Materials and methods

Samples collection

From July to August 2023, fecal samples were collected from diarrheic calves at 10 large-scale dairy or beef cattle farms located in Shizuishan, Wuzhong, Zhongwei, and Guyuan cities in Ningxia Hui Autonomous Region. A total of 100 fecal samples were collected, with 10 samples obtained from each farm (Table 1). Each sample was labeled using a unique patient ID that incorporated the initials of the sampling city in Pinyin.

Table 1

Table 1. Basic information of the sampled cattle farms.

Isolation and identification of bacteria and detection of virulence genes

Fecal samples were 10-fold diluted in peptone buffer, and 0.2 mL of the diluted suspension was inoculated into LB broth and incubated at 37°C until the logarithmic growth phase. The cultures were then transferred onto E. coli chromogenic medium and Salmonella chromogenic medium and incubated at 37°C for 16–18 h. A single purified colony was selected using an inoculation loop for Gram staining and microscopic observation. Bacterial genomic DNA was extracted (24), and PCR amplification was performed using specific primers. The amplification system contained 3.5 μL of Taq PCR Master Mix (Dining, China), 0.5 μL each of forward and reverse primers, 0.5 μL of DNA template, and 5 μL of dd H₂O. PCR products were analyzed by 1.5% agarose gel electrophoresis (Dining, China) and visualized using a gel imaging system. Additionally, PCR was used to detect virulence genes of E. coli and Salmonella. Primers were designed based on sequences from the NCBI database. The bacterial primer sequences and annealing temperatures are shown in Table 2, and virulence gene primers are listed in Table 3. All media were purchased from Qingdao Hope Biotechnology Co., Qingdao, China. The E. coli strain ATCC^® 25922 and Salmonella strain ATCC^® 12002 preserved in our laboratory was used as a control.

Table 2

Table 2. Sequence of 16S rDNA specific gene primers of bacteria.

Table 3

Table 3. Sequence of primers targeting virulence genes.

Antibiotic susceptibility testing

Antibiotic susceptibility was determined according to the standards of the Clinical and Laboratory Standards Institute (CLSI, 2023) using the broth microdilution method. A total of nine classes of commonly used veterinary antibiotics were tested (Shanghai Xingbai Biotechnology Co., Ltd., China). The test bacterial strains and reference strains were prepared as bacterial suspensions with a final concentration of 0.5 × 10⁵ CFU/mL. Using an 8-channel pipette, 100 μL of each working solution was added to the wells of the susceptibility testing plate. Negative and positive controls were included. After incubation at 37°C for 16–18 h, results were recorded by observing the wells. The lowest concentration of the antibiotic that showed no visible bacterial growth (clear well) was recorded as the minimum inhibitory concentration (MIC).

Checkerboard assay

The checkerboard method was used to evaluate the combined antibacterial activity of the Chinese herbal formula and Microcin J25 against E. coli and Salmonella isolated from diarrheic calves (25). Briefly, four herbal extracts—Populus tomentosa male flower, Portulaca oleracea, Sanguisorba officinalis, and Euphorbia humifusa (Sichuan Hengrui Tongda Biotechnology Co., Ltd., China)—were mixed in equal proportions to prepare the Chinese herbal formula. All four herbal extracts were prepared according to the water extraction and alcohol precipitation method specified in the Chinese Pharmacopoeia (2025 edition), with a standardized concentration of 1 g extract equivalent to 10 g crude drug. The formula and Microcin J25 (Zhongnong Yingtai Biotechnology Co., Ltd., China) were then diluted to seven gradient concentrations ranging from 1/16 MIC to 2 MIC. In a 96-well microtiter plate, each column contained a fixed concentration of drug A, and each row contained a fixed concentration of drug B. The first row and column served as monotherapy controls, and the well at the intersection (origin) served as the positive control. The initial bacterial concentration in each well was adjusted to approximately 0.5 × 10⁵ CFU/mL. E. coli ATCC^® 25,922 and Salmonella ATCC^® 12,002 were used as standard reference strains. After incubation at 37°C for 16–18 h, the results were recorded. The experiment was repeated in triplicate. FICI was calculating by given formula: FICI was calculating by given formula: FICI was calculated as the sum of the MIC of Chinese Herbal Formula in combination divided by the MIC of Chinese Herbal Formula alone, and the MIC of Microcin J25 in combination divided by the MIC of Microcin J25 alone. FICI≤0.5 means “synergy”; 0.5 < FICI≤0.75 means “partial synergy”; 0.76 < FICI≤1 denotes “additive”; 1 < FICI≤4 denotes “indifferent”; while “antagonistic” in cases which the FIC index > 4 (26).

Growth curve assay

As previously described, the growth curve assay was performed with slight modifications (27). The growth-inhibitory effects of the Chinese herbal formula and Microcin J25, alone or in combination, against E. coli and Salmonella were evaluated by growth curve analysis. The experiment was divided into four groups: control (no treatment), Microcin J25 alone, Chinese herbal formula alone, and a combination treatment in which both Microcin J25 and the Chinese herbal formula were administered together. The concentrations used were 0.25 × MIC for single treatments and 0.25 × MIC each for the combination group. Each group was inoculated with standardized bacterial suspension (final concentration: ~0.5 × 10⁵ CFU/mL) and incubated at 37°C. Aliquots of 100 μL from each group were sampled every 2 h for 18 h, and bacterial growth was monitored by measuring the optical density at OD₆₀₀ using a microplate reader. Each experiment was performed in triplicate, and the growth curves were plotted to compare the inhibitory effects of different treatments over time.

Determination of virulence gene downregulation

The relative expression levels of virulence genes in isolated strains were determined by real-time quantitative fluorescence PCR (RT-qPCR). RNA extraction was performed using the triazole method, with RNA concentration determined by spectrophotometry and integrity assessed via agarose gel electrophoresis. Subsequently, cDNA synthesis was carried out using an Integrated First-strand cDNA Synthesis kit, followed by RT-qPCR analysis using 2 × Fast HS SYBR QPCR Mixture. The amplification protocol was as follows: 95.0°C for 30 s; 95.0°C for 5 s, 60.0°C for 34 s, for a total of 40 cycles; followed by 95.0°C for 15 s, 60.0°C for 1 min, and 95.0°C for 15 s. The resulting qPCR data were analyzed for relative changes in gene expression levels based on the 2^−∆∆Ct method. Primers listed in Table 3 were utilized for this study.

Clinical prevention trial of calf diarrhea

Eighty healthy Holstein calves aged between 7 and 14 days were randomly divided into eight groups, with ten calves per group. The groups included: a negative control group (fed with standard pasteurized milk, referred to as NC); low-, medium-, and high-dose Chinese herbal formula groups (administered at doses of 0.05 g, 0.1 g, and 0.2 g per kilogram of body weight, referred to as CHFL, CHFM, and CHFH, respectively); a Microcin J25 group (supplemented at a concentration of 0.8 g per liter of milk, referred to as MCJ); and three combination groups receiving the same doses of the Chinese herbal formula along with 0.8 g per liter of Microcin J25 (referred to as COML, COMM, and COMH, respectively). The trial lasted for 7 days. Except for the control group, all groups were supplemented with the respective agents via milk feeding twice daily. Fecal scores were defined as follows: 0 indicated firm, well-formed feces; 1, slightly loose feces; 2, unformed loose feces; and 3, watery diarrhea (28). At the end of the trial, blood and rectal swab samples were collected for further analysis.

Clinical trial for the treatment of calf diarrhea

Twenty diarrheic Holstein calves aged between seven and 14 days were randomly divided into four treatment groups, with five calves in each group. The groups included: an enrofloxacin group (ENR), a Microcin J25 group (MCJ), a Chinese herbal formula group (CHF), and a combination group (COM). The trial lasted for 7 days. The treatment regimens were as follows: calves in the enrofloxacin group received intramuscular injections of enrofloxacin at a dose of 0.1 milliliters per kilogram of body weight once daily; the Microcin J25 group received 0.8 g of Microcin J25 per liter of milk daily; the CHF group was administered the herbal formula at 0.1 g per kilogram of body weight daily; and the combination group received both the herbal formula (0.1 g per kilogram of body weight) and Microcin J25 (0.8 g per liter of milk) daily. Fecal scores were recorded daily. Clinical resolution was defined as maintaining a fecal score below 2 for ≥2 consecutive days. At the end of the trial, blood and rectal swab samples were collected for analysis.

16S rDNA gene sequencing for analysis of gut microbiota

After thawing the collected calf anal swabs, microbial genomic DNA was extracted using a DNA extraction kit (Meiji Biotechnology Co., Ltd., Guangzhou, China) and detected by agarose gel electrophoresis. The V3-V4 hypervariable regions of bacterial 16S rDNA were amplified using specific primers: 341F (5′-CCTAYGGGRBGCASCAG-3′) and 806R (5′-GGACTACNNGGG TATCTAAT-3′). PCR products were purified with magnetic beads, pooled based on concentration, and target bands were excised for library construction. The constructed libraries were quantified using Qubit® and RT-qPCR. Qualified libraries were sequenced on the Illumina MiSeq platform (PE250 mode, Novaseq 6,000 system). Sample data were demultiplexed based on barcode and primer sequences. After removing barcodes and primers, paired-end reads were merged using FLASH to generate raw Tags. Reverse primer sequences were trimmed with Cutadapt to minimize interference in downstream analyses. Raw Tags were rigorously filtered with fastp to obtain high-quality Tags, which were then aligned against a reference database for chimera removal, yielding final effective OTUs. The validated OTUs were subjected to clustering analysis. Subsequent analyses included OTUs abundance profiling, alpha diversity (within-sample diversity), beta diversity (between-sample diversity), and taxonomic composition.

Statistical analysis

All experimental data were analyzed and visualized using GraphPad Prism 8. In all comparisons, p < 0.01 or p < 0.05 was considered statistically significant.

Results

Isolates of E. coli and Salmonella from the samples

Among the 100 fecal samples collected from diarrheic calves, a total of 97 E. coli and 20 Salmonella isolates were recovered (Figure 1A). All 97 E. coli isolates were sensitive to carbapenems. The highest resistance rate was observed against sulfonamides (83.5%), followed by resistance to amphenicols (24.8%), cephalosporins (19.6%), aminoglycosides (12.4%), quinolones (10.3%), tetracyclines (9.3%), penicillins (5.2%), and polymyxins (2.1%) (Figure 1B). All 20 Salmonella isolates were also sensitive to carbapenems and polymyxins, but exhibited the highest resistance to sulfonamides (75.0%), followed by aminoglycosides (50.0%), tetracyclines (25.0%), penicillins (15.0%), quinolones (10.0%), amphenicols (10.0%), and cephalosporins (5.0%) (Figure 1C).

Figure 1

Figure 1. (A) Isolation rate of E. coli and Salmonella.(B) Antibiotic resistance rates of 97 identified E. coli strains against 9 antibiotic classes.(C) Antibiotic resistance rates of 20 identified Salmonella strains against 9 antibiotic classes.(D) Detection rates of 5 virulence genes in 97 identified E. coli strains.(E) Detection rates of 5 virulence genes in 20 identified Salmonella strains.

Among the E. coli isolates, the F41 virulence gene had the highest detection rate (39.2%), followed by eaeA (23.7%), STX1 (6.2%), STX2 (2.1%), and STa (1%) (Figure 1D). For Salmonella, the most frequently detected virulence gene was spvC (45%), followed by sopE and invA (both 35%), fimA (30%), and stn (25%) (Figure 1E).

Synergistic antibacterial assay

To evaluate the potential synergistic effect of the Chinese herbal formula in combination with Microcin J25, the minimum inhibitory concentrations (MIC) of each agent against 97 previously identified E. coli and 20 Salmonella isolates were determined. Subsequently, checkerboard assays and bacterial growth curve analyses were conducted on three E. coli strains (GY3-5E, GY3-7E, ZW1-5E) and three Salmonella strains (GY3-2S, GY2-4S, ZW1-10S) harboring multiple virulence genes. The MIC of individual agents are shown in Figure 2A. As illustrated in Figure 2B and detailed in Table 4, the combination of the Chinese herbal formula with Microcin J25 exhibited partial synergy against the E. coli reference strain and either partial synergy or additive effects against the remaining E. coli isolates. For Salmonella, synergistic effects were observed against the reference strain, while partial synergy or indifferent interactions were observed for the clinical isolates.

Figure 2

Figure 2. (A) MIC of Chinese herbal formulas and Microcin J25 against the isolated E. coli and Salmonella strains.(B) Synergistic antibacterial effect determined by the checkerboard method.(C) Inhibition of growth in E. coli and Salmonella by Chinese herbal formulas and Microcin J25.(D) Effect of Chinese herbal formulas and Microcin J25 on the relative mRNA expression of virulence genes in E. coli.(E) Effect of Chinese herbal formulas and Microcin J25 on the relative mRNA expression of virulence genes in Salmonella. All data were expressed as mean ± SD values with three independent experiments performed in triplicate.^*p < 0.05; ^***p < 0.001; ^****p < 0.0001.

Table 4

Table 4. FICI values of Chinese herbal formulas combined with Microcin J25.

Importantly, as shown in Figure 2C, the combination treatment consistently suppressed the growth of both E. coli and Salmonella. In E. coli, no significant changes were observed in the mRNA expression levels of F41, eaeA, and STX1 (p > 0.05). However, the expression of STX2 was significantly reduced in the Microcin J25, Chinese herbal formula, and combination groups compared with the control group (p < 0.001), with the most pronounced inhibition observed in the combination group. In addition, the expression of STa was significantly reduced in the Microcin J25 group compared with the control (p < 0.05) (Figure 2D). For Salmonella, the expression levels of stn, fimA, and invA were unchanged following treatment (p > 0.05). The expression of sopE was significantly downregulated in the combination group compared to the control (p < 0.05), and spvC expression was markedly decreased in the Microcin J25, Chinese herbal formula, and combination groups (p < 0.0001), with the greatest effect observed in the combination treatment (Figure 2E).

Effects of combined application on fecal scores, diarrhea, and immunoglobulins of healthy calves

As shown in Table 5, all treatment groups exhibited lower fecal scores compared to the NC group. On day 5, the fecal scores in the MCJ, CHFM, CHFH, COML, COMM, and COMH groups were significantly lower than those in the NC group (p < 0.05). The highest diarrhea incidence was observed in the NC group at 50%, whereas the MCJ group showed a marked reduction to 20%. The diarrhea rates in the CHFL, CHFM, and CHFH groups were also reduced compared to the NC group, with the CHFM group showing the best effect at 20%. A further reduction in diarrhea incidence was observed in the combination groups, particularly in the COMM and COMH groups, which showed the lowest incidence at 10% (Figure 3A).

Table 5

Table 5. Effects of Chinese herbal formulas and Microcin J25 on fecal score of calves.

Figure 3

Figure 3. Effects of Chinese herbal formulas combined with Microcin J25 on diarrhea incidence and immunoglobulin levels in healthy calves. (A) Incidence of diarrhea in healthy calves treated with different groups. (B) Serum levels of IgA, IgG, and IgM in calves treated with different combinations. All data are expressed as mean ± SD. ^*p < 0.05; ^**p < 0.01. NC, Negative control group; MCJ, Calves treated with Microcin J25; CHFL, CHFM, CHFH, Calves treated with low, medium, and high-dose Chinese herbal formula. COML, COMM, COMH, Calves treated with low, medium, and high-dose Chinese herbal formula combined with Microcin J25, respectively.

Serum IgA levels in the COML, COMM, and COMH groups were significantly higher than those in the NC group (p < 0.05), while no significant changes were found in the MCJ, CHFL, CHFM, or CHFH groups (p > 0.05). Serum IgM levels were significantly elevated in the COMM and COMH groups compared to the NC group (p < 0.05), whereas no significant differences were observed in the MCJ, CHFL, CHFM, CHFH, or COML groups (p > 0.05). Serum IgG levels were significantly increased in the CHFM and CHFH groups (p < 0.05), and were markedly elevated in the COML, COMM, and COMH groups compared to both the NC and MCJ groups (p < 0.01) (Figure 3B).

Effects of combined application on the gut microbiota of healthy calves

Based on the above experimental results, the CHFM and COMM groups, which showed the best performance, were selected along with the NC and MCJ groups for 16S rDNA sequencing to explore their regulatory effects on the gut microbiota. As shown in Figure 4A, the Venn diagram of OTUs revealed that the CHF group had 268 OTUs, followed by the NC group with 128, the MCJ group with 81, and the COM group with 50. Figure 4B indicates that the sample points of the NC group were farther from those of the CHF and COM groups in the PCoA analysis, suggesting significant differences in microbial structure. The Chao1 and Shannon indices in the COM group were significantly decreased, while those in the CHF group increased significantly (p < 0.05), as shown in Figure 4C. At the phylum level (Figure 4D), Firmicutes was the dominant phylum in the NC, MCJ, and CHF groups, while both Firmicutes and Actinobacteriota dominated in the COM group. UCG-005 was the dominant genus in the NC and MCJ groups, Lactobacillus in the CHF group, and Bifidobacterium in the COM group. LEfSe analysis (Figure 4E) further showed that Lactobacillus mucosae, Methanocorpusculum, and Methanocorpusculaceae were significantly enriched in the CHF group. Meanwhile, Bifidobacterium breve and Collinsella were enriched in the COM group. These findings indicate that CHF improved gut microbiota diversity and stability in calves, increasing the abundance of beneficial bacteria, while COM mainly enhanced the abundance of specific probiotics.

Figure 4

Figure 4. Comparison of gut microbiota structure and distribution across different treatment groups. (A) Venn diagram showing the overlap of OTUs between different groups. (B) Beta diversity analysis. (C) Alpha diversity analysis. (D) Relative abundance of microbiota at the phylum and genus levels. (E) Linear discriminant analysis (LDA) was used to identify the most differentially abundant bacterial taxa among groups, with only those having an LDA score >3.0 shown. ^*p < 0.05. NC, Negative control group; MCJ, Calves treated with Microcin J25; CHF, Calves treated with Chinese herbal formula. COM, Calves treated with Chinese herbal formula combined with Microcin J25.

Effect of combination application on cure rate, recovery time, and cytokine levels of diarrheic calves

The cure rate was lowest in the CHF group at 20%, followed by the ENR group at 40%, while the COM group exhibited the highest cure rate at 80% (Figure 5A). The COM group showed a significantly shorter average recovery time than the MCJ group (p < 0.05) and a markedly shorter time than the CHF group (p < 0.01), indicating superior therapeutic efficacy (Figure 5B). Moreover, the COM group had significantly lower serum IL-1β and IL-6 levels compared to the other groups (p < 0.05) (Figure 5C).

Figure 5

Figure 5. Effects of Chinese herbal formulas combined with Microcin J25 on cure rate, recovery time, and inflammatory cytokines in diarrheic calves. (A) Cure rates of calves in different treatment groups. (B) Mean days to recovery in each group, showing the number of days required for recovery. (C) Serum levels of proinflammatory cytokines: IL-1β, IL-6, and TNF-α in different treatment groups. ^*p < 0.05; ^**p < 0.01; ^***p < 0.001. ENR, Calves treated with enrofloxacin; MCJ, Calves treated with Microcin J25 alone; CHF, Calves treated with Chinese herbal formulas alone; COM, Calves treated with a combination of Chinese herbal formulas and Microcin J25.

Effect of combination application on the gut microbiota of diarrheic calves

As shown in the Venn diagram (Figure 6A), the number of OTUs detected in the ENR, CHF, MCJ, and COM groups was 40, 43, 120, and 165, respectively. The COM group exhibited a distinct scatter distribution from the ENR and MCJ groups in PCoA analysis, indicating substantial differences in microbial community structures between these groups (Figure 6B). Compared to the other three groups, the COM group showed significantly higher Chao1 and Shannon indices (p < 0.05), suggesting increased richness and diversity (Figure 6C).

Figure 6

Figure 6. Comparison of gut microbiota structure and distribution across different treatment groups. (A) Venn diagram showing the overlap of OTUs between different groups. (B) Beta diversity analysis. (C) Alpha diversity analysis. (D) Relative abundance of microbiota at the phylum and genus levels. (E) Linear discriminant analysis (LDA) was used to identify the most differentially abundant bacterial taxa among groups, with only those having an LDA score >3.0 shown. ^*p < 0.05; ^**p < 0.01; ^***p < 0.001. ENR, Calves treated with enrofloxacin; MCJ, Calves treated with Microcin J25 alone; CHF, Calves treated with Chinese herbal formulas alone; COM, Calves treated with a combination of Chinese herbal formulas and Microcin J25.

At the phylum level, Firmicutes was the dominant phylum in both the CHF and COM groups, while Firmicutes and Proteobacteria were dominant in the ENR group. At the genus level, Escherichia-Shigella was predominant in the ENR and MCJ groups, while Enterococcus, Streptococcus, and Peptostreptococcus were dominant in the CHF group. In contrast, Collinsella, Lactobacillus, and Blautia were enriched in the COM group (Figure 6D). LEfSe analysis further revealed higher abundance of Escherichia-Shigella and Enterococcus in the ENR group; increased Ruminococcus, Blautia, and Clostridium in the MCJ group; elevated Lactobacillus, Bacillus, and Peptostreptococcus in the CHF group; and increased Lactobacillus, Bifidobacterium, and Clostridium in the COM group (Figure 6E).

These findings indicate that the combination of Chinese herbal formula and Microcin J25 effectively reduced the abundance of harmful bacteria while enriching beneficial microbes in the gut of diarrheic calves, thereby improving the overall microbial structure.

Correlation analysis of intestinal flora, anti-inflammatory factors, and immunoglobulins

Subsequently, correlation analyses were performed among anti-inflammatory factors, immunoglobulins, and dominant bacterial taxa detected in rectal swabs (Figure 7). The abundance of Euryarchaeota showed a highly significant positive correlation with serum IgM levels (p < 0.01). A significant positive correlation was observed between Lactobacillus abundance and serum IL-6 levels (p < 0.05), whereas Bifidobacterium abundance exhibited a significant negative correlation with serum IL-6 levels (p < 0.05). These findings suggest that the combined treatment of Chinese herbal formula and Microcin J25 may improve anti-inflammatory status and immune function in calves through modulation of gut microbiota composition.

Figure 7

Figure 7. The heatmap illustrates Pearson correlation coefficients among anti-inflammatory factors, immunoglobulins, and gut microbiota. *p < 0.05, **p < 0.01. n = 3.

Discussion

Diarrhea is one of the most common gastrointestinal diseases in calves, causing significant economic losses to the global livestock industry (29). Infectious diarrhea remains a leading cause of morbidity and mortality in neonatal calves (30). The most prevalent pathogens involved in neonatal calf diarrhea include bacteria (such as E. coli and Salmonella), viruses (such as rotavirus and coronavirus), and protozoa (such as Cryptosporidium) (31, 32). Bacterial infections, particularly those caused by pathogenic E. coli and Salmonella, are considered major contributors to calf diarrhea outbreaks in farms. In this study, 100 fecal samples from diarrheic calves were collected from four cities in Ningxia, from which 97 E. coli and 20 Salmonella isolates were identified. Most of these isolates exhibited high resistance to sulfonamides, suggesting that sulfonamide antibiotics may be ineffective for treating calf diarrhea in this region. Reducing antibiotic misuse and enhancing surveillance of resistant bacterial strains are essential strategies for improving calf health (33). Additionally, virulence gene analysis showed high detection rates of E. coli F41 and Salmonella spvC, indicating that strains carrying these genes may possess strong pathogenicity.

Due to the reduced efficacy of antibiotics in treating calf diarrhea, alternative strategies are urgently needed (34). Antimicrobial peptides, such as Microcin J25, show strong antimicrobial activity, immunomodulatory effects, and gut microbiota regulation potential (19, 35–40). However, their clinical application remains limited. The Chinese herbal formula used in this study, composed of Populus tomentosa male flower, Portulaca oleracea, Euphorbia humifusa, and Sanguisorba officinalis, contains bioactive flavonoids, polysaccharides, and organic acids with known anti-inflammatory and gut-protective effects (41–45). We demonstrated that herbal formula combined with Microcin J25 showed partial or full synergy against E. coli and Salmonella in vitro. The combination more effectively inhibited bacterial growth than either agent alone and significantly downregulated the expression of key virulence genes, including STX2 in E. coli and spvC in Salmonella, consider citing specific mechanisms from literature. This mechanism may be related to the destruction of bacterial biofilms. Relevant research reports indicate that the combined use of Chinese herbal medicines and polypeptide antibacterial substances triggers synergistic antibacterial effects by increasing cell membrane permeability, promoting intracellular ROS production, and inhibiting the expression of the mcr-1 gene (46).

Calf diarrhea disrupts intestinal microbiota and reduces immunity, making microbiota regulation and immune enhancement key to prevention (29, 47). Previous studies have shown that both Chinese herbal formulas and Microcin J25 improve gut health and reduce diarrhea in animals (48–50), though their combined use has not been reported. Based on in vitro synergy, we hypothesized that their combination could also be effective in vivo. As diarrhea is common in calves under 14 days, we selected seven-to fourteen-day-old calves to avoid colostrum influence. The combined treatment (COM) group showed the lowest diarrhea rates at 10%, with COMM and COMH being most effective, indicating strong preventive potential. Further trials are needed to clarify dose-dependence. Immunoglobulins are key indicators of humoral immunity (51). IgA protects mucosal surfaces, IgG mediates specific immune responses, and IgM is the first antibody produced after infection (52). CHF significantly increased serum immunoglobulins, and COM showed even greater improvement. Given the immature gut microbiota of neonatal calves (53), maintaining microbial diversity is critical. 16S rDNA sequencing revealed that CHF alone significantly increased Chao1 and Shannon indices, improving microbial diversity. Firmicutes dominated in healthy calves, consistent with previous studies (54). While COM increased beneficial bacteria, diversity declined, possibly due to enhanced antimicrobial synergy. Thus, COM may suit acute-phase intervention, while CHF alone is preferable for long-term gut stability.

Currently, large-scale cattle farms primarily rely on broad-spectrum antibiotics to treat calf diarrhea. However, such treatments can disrupt the gut microbiota, leading to a reduction in beneficial bacteria, an increase in resistant strains, and drug residues (55). In this study, we found that the cure rate in the COM group reached 80%, significantly higher than enrofloxacin, Microcin J25, or the herbal formula alone. Additionally, the COM group had a shorter recovery time compared to the ENR group. Proinflammatory cytokines such as IL-1β, IL-6, and TNF-α are key mediators of immune and inflammatory responses and are closely associated with the pathogenesis of diarrhea. When the intestinal barrier is compromised, pathogens can invade and trigger inflammation (56–59). Calves in the COM group showed significantly lower levels of IL-1β and IL-6, suggesting that the combination therapy effectively alleviated intestinal inflammation. Gut microbiota plays a vital role in both the onset and resolution of diarrhea (60). The COM group showed significantly higher Chao1 and Shannon indices than the other groups, indicating improved microbial richness and diversity. Diarrheic calves typically exhibit an overgrowth of Proteobacteria, a marker of dysbiosis and diarrhea risk (61). In the COM group, the relative abundance of Firmicutes, Lactobacillus, and Bifidobacterium increased, while Proteobacteria and Escherichia-Shigella decreased. This suggests that the combination treatment promoted beneficial bacteria, suppressed harmful bacteria, and helped restore microbial balance (62). In contrast, the ENR group showed higher levels of Proteobacteria and Escherichia-Shigella, indicating potential microbiota disruption due to prolonged antibiotic use. Furthermore, the abundance of Euryarchaeota was extremely significantly positively correlated with the level of serum IgM. The abundance of Bifidobacterium was significantly negatively correlated with the level of serum IL-6. This indicates that the traditional Chinese herbal formula and Microcin J25 may enhance the immune function and anti-inflammatory ability of calves by regulating the intestinal flora.

In conclusion, our study showed a high prevalence of E. coli, Salmonella, and their associated virulence genes in diarrheic calves in the Ningxia region, which warrants attention. Notably, the combination of Chinese herbal formulas and Microcin J25 exhibited synergistic antibacterial activity against E. coli and Salmonella. Clinically, this combination reduced diarrhea incidence, improved cure rates, enhanced immunity, alleviated inflammatory responses, and helped regulate gut microbiota composition in calves. These findings highlight the great potential of Chinese herbal medicine and antimicrobial peptides in the prevention and treatment of calf diarrhea.

Data availability statement

The data presented in the study are deposited in the NCBI repository, accession number PRJNA1281273.

Ethics statement

The experiments were conducted in accordance with the guidelines of the Chinese Committee for the Care and Use of Laboratory Animals. The animal study was reviewed and approved by the Institutional Animal Care and Use Committee and Ethics Committee of Northwest A&F University (approval number: NWLA-2021-063). The study was conducted in accordance with the local legislation and institutional requirements.

Author contributions

D-ZD: Writing – review & editing, Investigation, Conceptualization, Writing – original draft, Validation, Data curation, Formal analysis, Methodology. L-XZ: Investigation, Writing – original draft, Methodology, Data curation, Formal analysis. QS: Conceptualization, Writing – original draft, Investigation. XL: Data curation, Writing – original draft, Methodology. Y-CT: Methodology, Writing – review & editing, Conceptualization, Data curation. WZ: Data curation, Conceptualization, Writing – original draft, Methodology. Y-PF: Methodology, Supervision, Conceptualization, Writing – review & editing, Formal analysis, Data curation. QY: Conceptualization, Writing – review & editing, Methodology, Supervision, Formal analysis. F-JW: Writing – original draft, Data curation, Methodology, Conceptualization. S-ZQ: Formal analysis, Data curation, Conceptualization, Supervision, Writing – review & editing, Writing – original draft, Methodology. W-MZ: Formal analysis, Writing – review & editing, Data curation, Methodology, Writing – original draft, Conceptualization, Supervision.

Funding

The author(s) declare that financial support was received for the research and/or publication of this article. This study was funded by the 2025 Municipal R&D Program for Agriculture and Rural Affairs of Zhongwei City (2024nync004) and the Key R&D Project of the Ningxia Hui Autonomous Region on the Application of Key Technologies for Reducing the Use of Veterinary Antibiotics in Livestock and Poultry Farms (2021BEF02041).

Acknowledgments

The authors thank all individuals who contributed to this study for their assistance and support.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The authors declare that no Gen AI was used in the creation of this manuscript.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Cho, YI, and Yoon, KJ. An overview of calf diarrhea - infectious etiology, diagnosis, and intervention. J Vet Sci. (2014) 15:1–17. doi: 10.4142/jvs.2014.15.1.1

PubMed Abstract | Crossref Full Text | Google Scholar

2. Bergholm, J, Tessema, TS, Blomström, AL, and Berg, M. Detection and molecular characterization of major enteric pathogens in calves in Central Ethiopia. BMC Vet Res. (2024) 20:389. doi: 10.1186/s12917-024-04258-7

PubMed Abstract | Crossref Full Text | Google Scholar

3. Wang, D, Gao, H, Zhao, L, Lv, C, Dou, W, Zhang, X, et al. Detection of the dominant pathogens in diarrheal calves of Ningxia, China in 2021-2022. Front Vet Sci. (2023) 10:1155061. doi: 10.3389/fvets.2023.1155061

PubMed Abstract | Crossref Full Text | Google Scholar

4. Shen, L, Shen, Y, You, L, Zhang, Y, Su, Z, Peng, G, et al. Pueraria lobata polysaccharides alleviate neonatal calf diarrhea by modulating gut microbiota and metabolites. Front Vet Sci. (2023) 9:1024392. doi: 10.3389/fvets.2022.1024392

PubMed Abstract | Crossref Full Text | Google Scholar

5. Du, W, Wang, X, Hu, M, Hou, J, Du, Y, Si, W, et al. Modulating gastrointestinal microbiota to alleviate diarrhea in calves. Front Microbiol. (2023) 14:1181545. doi: 10.3389/fmicb.2023.1181545

PubMed Abstract | Crossref Full Text | Google Scholar

6. Abdank, L, Loncaric, I, Braun, SD, Müller, E, Monecke, S, Ehricht, R, et al. Characterizing methicillin-resistant Staphylococcus spp. and extended-Spectrum cephalosporin-resistant Escherichia coli in cattle. Animals. (2024) 14:3383. doi: 10.3390/ani14233383

PubMed Abstract | Crossref Full Text | Google Scholar

7. Kupczyński, R, Bednarski, M, Sokołowski, M, Kowalkowski, W, and Pacyga, K. Comparison of antibiotic use and the frequency of diseases depending on the size of herd and the type of cattle breeding. Animals. (2024) 14:1889. doi: 10.3390/ani14131889

PubMed Abstract | Crossref Full Text | Google Scholar

8. Almansour, AM, Alhadlaq, MA, Alzahrani, KO, Mukhtar, LE, Alharbi, AL, and Alajel, SM. The silent threat: antimicrobial-resistant pathogens in food-producing animals and their impact on public health. Microorganisms. (2023) 11:2127. doi: 10.3390/microorganisms11092127

PubMed Abstract | Crossref Full Text | Google Scholar

9. Shi, Z, Lan, Y, Wang, Y, Yan, X, Ma, X, Hassan, F-u, et al. Multi-omics strategy reveals potential role of antimicrobial resistance and virulence factor genes responsible for Simmental diarrheic calves caused by Escherichia coli. mSystems. (2024) 9:e0134823. doi: 10.1128/msystems.01348-23

PubMed Abstract | Crossref Full Text | Google Scholar

10. Lee, KY, Atwill, ER, Li, X, Feldmann, HR, Williams, DR, Weimer, BC, et al. Impact of zinc supplementation on phenotypic antimicrobial resistance of fecal commensal bacteria from pre-weaned dairy calves. Sci Rep. (2024) 14:4448. doi: 10.1038/s41598-024-54738-x

PubMed Abstract | Crossref Full Text | Google Scholar

11. Afema, JA, Davis, MA, and Sischo, WM. Antimicrobial use policy change in pre-weaned dairy calves and its impact on antimicrobial resistance in commensal Escherichia coli: a cross sectional and ecological study. BMC Microbiol. (2019) 19:217. doi: 10.1186/s12866-019-1576-6

PubMed Abstract | Crossref Full Text | Google Scholar

12. Ellward, GL, Binda, ME, Dzurny, DI, Bucher, MJ, Dees, WR, and Czyż, DM. A screen of traditional Chinese medicinal plant extracts reveals 17 species with antimicrobial properties. Antibiotics. (2024) 13:1220. doi: 10.3390/antibiotics13121220

PubMed Abstract | Crossref Full Text | Google Scholar

13. Yang, SQ, Ge, YJ, and Shen, CY. Disclosing antifungal activity of Huangqin decoction upon Trichophyton mentagrophytes and exploring its potential inhibitory mechanisms through transcriptome sequencing and qRT-PCR. Sci Rep. (2025) 15:13321. doi: 10.1038/s41598-025-97689-7

PubMed Abstract | Crossref Full Text | Google Scholar

14. Che, Q, Luo, T, Shi, J, He, Y, and Xu, DL. Mechanisms by which traditional Chinese medicines influence the Intestinal Flora and Intestinal barrier. Front Cell Infect Microbiol. (2022) 12:863779. doi: 10.3389/fcimb.2022.863779

PubMed Abstract | Crossref Full Text | Google Scholar

15. Du, T, Zhu, W, Zhang, C, Liang, X, Shu, Y, Zhou, J, et al. Bacteriostatic activity and resistance mechanism of Artemisia annua extract against Ralstonia solanacearum in pepper. Plants. (2025) 14:651. doi: 10.3390/plants14050651

PubMed Abstract | Crossref Full Text | Google Scholar

16. Cheng, G, Hao, H, Xie, S, Wang, X, Dai, M, Huang, L, et al. Antibiotic alternatives: the substitution of antibiotics in animal husbandry? Front Microbiol. (2014) 5:217. doi: 10.3389/fmicb.2014.00217

PubMed Abstract | Crossref Full Text | Google Scholar

17. Ji, Q, Zhou, B, Shen, T, Jiang, T, Cheng, C, and He, B. The lasso structure, biosynthesis, bioactivities and potential applications of Microcin J25: a novel antibacterial agent with unique mechanisms. Eng Microbiol. (2023) 3:100096. doi: 10.1016/j.engmic.2023.100096

PubMed Abstract | Crossref Full Text | Google Scholar

18. Yu, H, Shang, L, Yang, G, Dai, Z, Zeng, X, and Qiao, S. Biosynthetic Microcin J25 exerts strong antibacterial, anti-inflammatory activities, low cytotoxicity without increasing drug-resistance to Bacteria target. Front Immunol. (2022) 13:811378. doi: 10.3389/fimmu.2022.811378

PubMed Abstract | Crossref Full Text | Google Scholar

19. Lopez, FE, Vincent, PA, Zenoff, AM, Salomón, RA, and Farías, RN. Efficacy of microcin J25 in biomatrices and in a mouse model of Salmonella infection. J Antimicrob Chemother. (2007) 59:676–80. doi: 10.1093/jac/dkm009

PubMed Abstract | Crossref Full Text | Google Scholar

20. Naimi, S, Zirah, S, Taher, MB, Theolier, J, Fernandez, B, Rebuffat, SF, et al. Microcin J25 exhibits inhibitory activity against Salmonella Newport in continuous fermentation model mimicking swine colonic conditions. Front Microbiol. (2020) 11:988. doi: 10.3389/fmicb.2020.00988

PubMed Abstract | Crossref Full Text | Google Scholar

21. Vincent, PA, and Morero, RD. The structure and biological aspects of peptide antibiotic microcin J25. Curr Med Chem. (2009) 16:538–49. doi: 10.2174/092986709787458461

PubMed Abstract | Crossref Full Text | Google Scholar

22. Ben Said, L, Emond-Rheault, JG, Soltani, S, Telhig, S, Zirah, S, Rebuffat, S, et al. Phenomic and genomic approaches to studying the inhibition of multiresistant Salmonella enterica by microcin J25. Environ Microbiol. (2020) 22:2907–20. doi: 10.1111/1462-2920.15045

PubMed Abstract | Crossref Full Text | Google Scholar

23. Zhang, L, Ben Said, L, Hervé, N, Zirah, S, Diarra, MS, and Fliss, I. Effects of drinking water supplementation with Lactobacillus reuteri, and a mixture of reuterin and microcin J25 on the growth performance, caecal microbiota and selected metabolites of broiler chickens. J Anim Sci Biotechnol. (2022) 13:34. doi: 10.1186/s40104-022-00683-6

PubMed Abstract | Crossref Full Text | Google Scholar

24. Tong, YC, Li, PC, Yang, Y, Lin, QY, Liu, JT, Gao, YN, et al. Detection of antibiotic resistance in feline-origin ESBL Escherichia coli from different areas of China and the resistance elimination of garlic oil to cefquinome on ESBL E. coli. Int J Mol Sci. (2023) 24:9627. doi: 10.3390/ijms24119627

PubMed Abstract | Crossref Full Text | Google Scholar

25. Draper, LA, Cotter, PD, Hill, C, and Ross, RP. The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit gram negative bacteria. BMC Microbiol. (2013) 13:212. doi: 10.1186/1471-2180-13-212

PubMed Abstract | Crossref Full Text | Google Scholar

26. Tong, YC, Zhang, YN, Li, PC, Cao, YL, Ding, DZ, Yang, Y, et al. Detection of antibiotic-resistant canine origin Escherichia coli and the synergistic effect of magnolol in reducing the resistance of multidrug-resistant Escherichia coli. Front Vet Sc. (2023) 10:1104812. doi: 10.3389/fvets.2023.1104812

PubMed Abstract | Crossref Full Text | Google Scholar

27. Wang, C, Lu, H, Li, X, Zhu, Y, Ji, Y, Lu, W, et al. Identification of an anti-virulence drug that reverses antibiotic resistance in multidrug resistant bacteria. Biomed Pharmacother. (2022) 153:113334. doi: 10.1016/j.biopha.2022.113334

PubMed Abstract | Crossref Full Text | Google Scholar

28. Wen, X, Wang, L, Zheng, C, Yang, X, Ma, X, Wu, Y, et al. Fecal scores and microbial metabolites in weaned piglets fed different protein sources and levels. Anim Nutr. (2018) 4:31–6. doi: 10.1016/j.aninu.2017.10.006

PubMed Abstract | Crossref Full Text | Google Scholar

29. Islam, J, Tanimizu, M, Shimizu, Y, Goto, Y, Ohtani, N, Sugiyama, K, et al. Development of a rational framework for the therapeutic efficacy of fecal microbiota transplantation for calf diarrhea treatment. Microbiome. (2022) 10:31. doi: 10.1186/s40168-021-01217-4

PubMed Abstract | Crossref Full Text | Google Scholar

30. Uhde, FL, Kaufmann, T, Sager, H, Albini, S, Zanoni, R, Schelling, E, et al. Prevalence of four enteropathogens in the faeces of young diarrhoeic dairy calves in Switzerland. Vet Rec. (2008) 163:362–6. doi: 10.1136/vr.163.12.362

PubMed Abstract | Crossref Full Text | Google Scholar

31. Izzo, MM, Kirkland, PD, Mohler, VL, Perkins, NR, Gunn, AA, and House, JK. Prevalence of major enteric pathogens in Australian dairy calves with diarrhoea. Aust Vet J. (2011) 89:167–73. doi: 10.1111/j.1751-0813.2011.00692.x

Crossref Full Text | Google Scholar

32. Zhao, JQ, Fan, YY, Lei, YD, Liu, D, Wang, JW, Yang, X, et al. Molecular characterization of common zoonotic protozoan parasites and bacteria causing diarrhea in dairy calves in Ningxia Hui autonomous region, China. Parasite. (2024) 31:60. doi: 10.1051/parasite/2024059

PubMed Abstract | Crossref Full Text | Google Scholar

33. Cannon, C, Kim, SW, Lee, JL, Van Kessel, JAS, and Haley, BJ. Antimicrobial-resistant Raoultella planticola isolated from preweaned dairy calf feces. J Glob Antimicrob Resist. (2025) 42:98–9. doi: 10.1016/j.jgar.2025.01.020

PubMed Abstract | Crossref Full Text | Google Scholar

34. Yan, Z, Zhang, K, Zhang, K, Wang, G, Wang, L, Zhang, J, et al. Huang Bai Jian PI decoction alleviates diarrhea and represses inflammatory injury via PI3K/Akt/NF-κB pathway: in vivo and in vitro studies. J Ethnopharmacol. (2022) 292:115212. doi: 10.1016/j.jep.2022.115212

PubMed Abstract | Crossref Full Text | Google Scholar

35. Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature. (2002) 415:389–95. doi: 10.1038/415389a

PubMed Abstract | Crossref Full Text | Google Scholar

36. Kamysz, W. Are antimicrobial peptides an alternative for conventional antibiotics? Nucl Med Rev Cent East Eur. (2005) 8:78–86.

Google Scholar

37. Baltzer, SA, and Brown, MH. Antimicrobial peptides: promising alternatives to conventional antibiotics. J Mol Microbiol Biotechnol. (2011) 20:228–35. doi: 10.1159/000331009

PubMed Abstract | Crossref Full Text | Google Scholar

38. Kang, SJ, Kim, DH, Mishig-Ochir, T, and Lee, BJ. Antimicrobial peptides: their physicochemical properties and therapeutic application. Arch Pharm Res. (2012) 35:409–13. doi: 10.1007/s12272-012-0302-9

PubMed Abstract | Crossref Full Text | Google Scholar

39. He, Y, Zhou, Y, Liu, N, Zhang, W, Chen, X, Qiu, G, et al. Cathelicidin LL-37 in periodontitis: current research advances and future prospects - a review. Int Immunopharmacol. (2025) 150:114277. doi: 10.1016/j.intimp.2025.114277

PubMed Abstract | Crossref Full Text | Google Scholar

40. Rebuffat, S, Blond, A, Destoumieux-Garzón, D, Goulard, C, and Peduzzi, J. Microcin J25, from the macrocyclic to the lasso structure: implications for biosynthetic, evolutionary and biotechnological perspectives. Curr Protein Pept Sci. (2004) 5:383–91. doi: 10.2174/1389203043379611

PubMed Abstract | Crossref Full Text | Google Scholar

41. Martínez-Esquivias, F, Guzmán-Flores, JM, Pech-Santiago, EO, Guerrero-Barrera, AL, Delgadillo-Aguirre, CK, and Anaya-Esparza, LM. Therapeutic role of quercetin in prostate Cancer: a study of network pharmacology, molecular docking, and dynamics simulation. Cell Biochem Biophys. (2025). doi: 10.1007/s12013-025-01697-3

PubMed Abstract | Crossref Full Text | Google Scholar

42. Wei, YH, Zhou, SM, Zhao, W, Chen, Q, Wang, QH, Yu, ML, et al. Normal butanol fraction of Polygonum hydropiper L. flavonoids reduces inflammation caused by PCV2 infections in cell and mouse models. Front Vet Sci. (2025) 12:1539448. doi: 10.3389/fvets.2025.1539448

PubMed Abstract | Crossref Full Text | Google Scholar

43. Pan, X, Xian, P, Li, Y, Zhao, X, Zhang, J, Song, Y, et al. Chemotaxis-driven hybrid liposomes recover intestinal homeostasis for targeted colitis therapy. J Control Release. (2025) 380:829–45. doi: 10.1016/j.jconrel.2025.02.036

PubMed Abstract | Crossref Full Text | Google Scholar

44. Li, Y, Zhou, X, Qi, S, Jia, G, Cao, J, Guan, Z, et al. Effects of Portulaca oleracea L. polysaccharide on piglets infected with porcine rotavirus. Microb Pathog. (2025) 200:107355. doi: 10.1016/j.micpath.2025.107355

PubMed Abstract | Crossref Full Text | Google Scholar

45. Cai, F, Huang, M, Liu, W, Wan, X, Qiu, K, and Xu, X. Dietary addition of compound organic acids improves the growth performance, carcass trait, and body health of broilers. Front Nutr. (2025) 12:1536606. doi: 10.3389/fnut.2025.1536606

PubMed Abstract | Crossref Full Text | Google Scholar

46. Liu, Y, Wang, Y, Kong, J, Jiang, X, Han, Y, Feng, L, et al. An effective antimicrobial strategy of colistin combined with the Chinese herbal medicine shikonin against colistin-resistant Escherichia coli. Microbiol Spectr. (2023) 11:e0145923. doi: 10.1128/spectrum.01459-23

PubMed Abstract | Crossref Full Text | Google Scholar

47. Yue, SJ, Liu, J, Wang, WX, Wang, AT, Yang, XY, Guan, HS, et al. Berberine treatment-emergent mild diarrhea associated with gut microbiota dysbiosis. Biomed Pharmacother. (2019) 116:109002. doi: 10.1016/j.biopha.2019.109002

PubMed Abstract | Crossref Full Text | Google Scholar

48. Naimi, S, Zirah, S, Greppi, A, Lacroix, C, Rebuffat, S, and Fliss, I. Impact of microcin J25 on the porcine microbiome in a continuous culture model. Front Microbiol. (2022) 13:930392. doi: 10.3389/fmicb.2022.930392

PubMed Abstract | Crossref Full Text | Google Scholar

49. Yu, HT, Ding, XL, Li, N, Zhang, XY, Zeng, XF, Wang, S, et al. Dietary supplemented antimicrobial peptide microcin J25 improves the growth performance, apparent total tract digestibility, fecal microbiota, and intestinal barrier function of weaned pigs. J Anim Sci. (2017) 95:5064–76. doi: 10.2527/jas2017.1494

PubMed Abstract | Crossref Full Text | Google Scholar

50. Guo, Q, Wang, J, Wang, X, Zhang, H, and Xing, J. Supplemented with Astragalus dregs improves growth performance, immunity, and antioxidant capacity in fattening pigs. J Nutr Sci. (2025) 14:e5. doi: 10.1017/jns.2024.95

PubMed Abstract | Crossref Full Text | Google Scholar

51. Li, X, An, N, Chen, H, and Liu, D. Effects of yeast culture on growth performance, antioxidant capacity, immune function, and intestinal microbiota structure in Simmental beef cattle. Front Vet Sci. (2025) 11:1533081. doi: 10.3389/fvets.2024.1533081

PubMed Abstract | Crossref Full Text | Google Scholar

52. Sun, P, Wang, JQ, and Zhang, HT. Effects of Bacillus subtilis natto on performance and immune function of preweaning calves. J Dairy Sci. (2010) 93:5851–5. doi: 10.3168/jds.2010-3263

PubMed Abstract | Crossref Full Text | Google Scholar

53. Wang, Y, Zhang, H, Zhu, L, Xu, Y, Liu, N, Sun, X, et al. Dynamic distribution of gut microbiota in goats at different ages and health states. Front Microbiol. (2018) 9:2509. doi: 10.3389/fmicb.2018.02509

PubMed Abstract | Crossref Full Text | Google Scholar

54. Zielińska, S, Kidawa, D, Stempniewicz, L, Łoś, M, and Łoś, JM. New insights into the microbiota of the Svalbard reindeer Rangifer tarandus platyrhynchus. Front Microbiol. (2016) 7:170. doi: 10.3389/fmicb.2016.00170

PubMed Abstract | Crossref Full Text | Google Scholar

55. Kim, HS, Whon, TW, Sung, H, Jeong, YS, Jung, ES, Shin, NR, et al. Longitudinal evaluation of fecal microbiota transplantation for ameliorating calf diarrhea and improving growth performance. Nat Commun. (2021) 12:161. doi: 10.1038/s41467-020-20389-5

PubMed Abstract | Crossref Full Text | Google Scholar

56. Yue, Y, He, Z, Zhou, Y, Ross, RP, Stanton, C, Zhao, J, et al. Lactobacillus plantarum relieves diarrhea caused by enterotoxin-producing Escherichia coli through inflammation modulation and gut microbiota regulation. Food Funct. (2020) 11:10362–74. doi: 10.1039/d0fo02670k

PubMed Abstract | Crossref Full Text | Google Scholar

57. Yang, B, Huang, Z, He, Z, Yue, Y, Zhou, Y, Ross, RP, et al. Protective effect of Bifidobacterium bifidum FSDJN7O5 and Bifidobacterium breve FHNFQ23M3 on diarrhea caused by enterotoxigenic Escherichia coli. Food Funct. (2021) 12:7271–82. doi: 10.1039/d1fo00504a

PubMed Abstract | Crossref Full Text | Google Scholar

58. Dong, N, Xue, C, Zhang, L, Zhang, T, Wang, C, Bi, C, et al. Oleanolic acid enhances tight junctions and ameliorates inflammation in Salmonella typhimurium-induced diarrhea in mice via the TLR4/NF-κB and MAPK pathway. Food Funct. (2020) 11:1122–32. doi: 10.1039/c9fo01718f

PubMed Abstract | Crossref Full Text | Google Scholar

59. Huang, C, Dong, J, Jin, X, Ma, H, Zhang, D, Wang, F, et al. Intestinal anti-inflammatory effects of fuzi-ganjiang herb pair against DSS-induced ulcerative colitis in mice. J Ethnopharmacol. (2020) 261:112951. doi: 10.1016/j.jep.2020.112951

PubMed Abstract | Crossref Full Text | Google Scholar

60. Turnbaugh, PJ, Ley, RE, Mahowald, MA, Magrini, V, Mardis, ER, and Gordon, JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. (2006) 444:1027–31. doi: 10.1038/nature05414

PubMed Abstract | Crossref Full Text | Google Scholar

61. Islam, J, Ohtani, N, Shimizu, Y, Tanimizu, M, Goto, Y, Sato, M, et al. Freeze-dried fecal microorganisms as an effective biomaterial for the treatment of calves suffering from diarrhea. Sci Rep. (2024) 14:28078. doi: 10.1038/s41598-024-79267-5

PubMed Abstract | Crossref Full Text | Google Scholar

62. Liu, X, Zhang, X, Liu, H, Fu, H, Liu, Y, Ge, Y, et al. Garlic-derived exosome-like nanoparticles enhance gut homeostasis in stressed piglets: involvement of Lactobacillus reuteri modulation and Indole-3-propionic acid induction. J Agric Food Chem. (2025) 73:7228–43. doi: 10.1021/acs.jafc.4c11506

PubMed Abstract | Crossref Full Text | Google Scholar